Toremifene Side Effects

Brand Names: Fareston

Please note - some side effects for Toremifene may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Toremifene - for the Consumer

Toremifene

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Toremifene:

Dizziness; hot flashes; joint pain; loss of appetite; nausea; sweating; swelling of the hands or feet; tiredness; vaginal discharge; vomiting.

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); change in vision; chest pain; confusion; depression; flushing; hallucinations; irregular heartbeat; muscle pain; unusual bleeding or bruising ; vaginal bleeding .

Side Effects by Body System

General

Hot flashes (35%), sweating (20%), and dizziness (9%) have been reported.

Gastrointestinal

Gastrointestinal effects including nausea (14%) and vomiting (4%) have been reported.

Genitourinary

Genitourinary effects including vaginal discharge (13%) and vaginal bleeding (2%) have been reported.

Ocular

Ocular effects including cataracts (up to 10%), dry eyes (up to 9%), abnormal visual fields (up to 4%), corneal keratopathy (up to 2%), glaucoma (<1% to 1.5%) and abnormal vision/diplopia (up to 1.5%) have been reported.

Cardiovascular

Cardiovascular effects including edema (5%), arrhythmia (up to 1.5%), cardiac failure (up to 1%), myocardial infarction (up to 1%), and angina pectoris (<1%) have been reported.

Hematologic

Hematologic effects including hypercalcemia (3%), pulmonary embolism (up to 2%), thrombophlebitis (up to 2%), CVA/TIA (up to 2%), and thrombosis (up to 1.5%) have been reported.

Hepatic

Hepatic effects including elevated test results in the following percent of patients have been reported, SGOT (5% to 19%), alkaline phosphatase (8% to 19%), and bilirubin (1% to 1.5%). Toxic hepatitis has also been reported.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.